SPONSOR
Second Xiangya Hospital of Central South University
Total Trials
3
Recruiting
3
Phases
Phase 1
Conditions studied: Locally Advanced Cervical CancerCachexiaLung CancerPsychological StressImmune Checkpoint InhibitorsCancer, Treatment-RelatedSmall Cell Lung Cancer (SCLC)
Second Xiangya Hospital of Central South University is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Locally Advanced Cervical Cancer, Cachexia, Lung Cancer, Psychological Stress.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Second Xiangya Hospital of Central South University
How many clinical trials has Second Xiangya Hospital of Central South University sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Second Xiangya Hospital of Central South University, of which 3 are actively recruiting participants. These trials cover conditions including Locally Advanced Cervical Cancer, Cachexia, Lung Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Second Xiangya Hospital of Central South University research focus on?
Second Xiangya Hospital of Central South University clinical trials span Locally Advanced Cervical Cancer, Cachexia, Lung Cancer, Psychological Stress, Immune Checkpoint Inhibitors, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Second Xiangya Hospital of Central South University clinical trial?
To participate in a Second Xiangya Hospital of Central South University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Second Xiangya Hospital of Central South University trials with current recruitment status updated daily.
Clinical Trials by Second Xiangya Hospital of Central South University
NCT07338487 Phase 1
Recruiting
A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Locally Advanced Cervical Cancer
NCT05477979
Recruiting
The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG)
Lung Cancer
NCT07886047 Phase 1
Recruiting
Propranolol Hydrochloride Combined With Adebrelimab and Platinum-Based Chemotherapy in Small Cell Lung Cancer
Small Cell Lung Cancer (SCLC)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology